Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 17/20 | 0.66 |
| ▸ | MAPK9 | P45984 | 15/20 | 0.66 |
| ▸ | MAPK10 | P53779 | 13/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.49 |
| ▸ | CDK2 | P24941 | 2/20 | 0.49 |
| ▸ | MKNK1 | Q9BUB5 | 3/20 | 0.46 |
| ▸ | MKNK2 | Q9HBH9 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3814586 | 0.88 | MAPK8 (0.70) | MAPK8MAPK9MAPK10CYP2C9CCNE1 | |
| SCHEMBL5094240 | 0.88 | MAPK8 (0.70) | MAPK8MAPK9MAPK10CYP2C9CCNE1 | |
| SCHEMBL3805465 | 0.82 | MAPK8 (0.73) | MAPK8MAPK9MAPK10CYP2C9CCNE1 | |
| SCHEMBL5093840 | 0.82 | MAPK8 (0.73) | MAPK8MAPK9MAPK10CYP2C9CCNE1 | |
| SCHEMBL5090208 | 0.82 | MAPK8 (0.73) | MAPK8MAPK9MAPK10CYP2C9CCNE1 | |
| SCHEMBL3814615 | 0.82 | MAPK8 (0.73) | MAPK8MAPK9MAPK10CYP2C9CCNE1 | |
| SCHEMBL5102042 | 0.82 | MAPK8 (0.69) | MAPK8MAPK9MAPK10CYP2C9CCNE1 | |
| SCHEMBL14175785 | 0.80 | MAPK8 (0.64) | MAPK8MAPK9MAPK10CYP2C9CCNE1 | |
| SCHEMBL14768388 | 0.80 | MAPK8 (0.64) | MAPK8MAPK9MAPK10CYP2C9CCNE1 | |
| SCHEMBL5096150 | 0.80 | MAPK8 (0.67) | MAPK8MAPK9MAPK10CYP2C9CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8399462-B2 | 4-[4-(4-benzyloxy-indol-1-yl)-pyrimidin-2-ylamino]-cyclohexanol; autoimmune, inflammatory, metabolic, neurological diseases as well as cancer and pain | ROCHE PALO ALTO LLC (US) | 2013-03-19 | — | — | US | disclosed |